A natural adhesive-based nanomedicine initiates photothermal-directed in situ immunotherapy with durability and maintenance

Yunhong He,Hong Sun,Hanxiao Bao,Jue Hou,Qiaomei Zhou,Fan Wu,Xuanhao Wang,Mingli Sun,Junhui Shi,Guping Tang,Hongzhen Bai

DOI: https://doi.org/10.1016/j.biomaterials.2024.122751

IF: 14

Biomaterials

Abstract:Tumor immunotherapies have emerged as a promising frontier in the realm of cancer treatment. However, challenges persist in achieving localized, durable immunostimulation while counteracting the tumor's immunosuppressive environment. Here, we develop a natural mussel foot protein-based nanomedicine with spatiotemporal control for tumor immunotherapy. In this nanomedicine, an immunoadjuvant prodrug and a photosensitizer are integrated, which is driven by their dynamic bonding and non-covalent assembling with the protein carrier. Harnessing the protein carrier's bioadhesion, this nanomedicine achieves a drug co-delivery with spatiotemporal precision, by which it not only promotes tumor photothermal ablation but also broadens tumor antigen repertoire, facilitating in situ immunotherapy with durability and maintenance. This nanomedicine also modulates the tumor microenvironment to overcome immunosuppression, thereby amplifying antitumor responses against tumor progression. Our strategy underscores a mussel foot protein-derived design philosophy of drug delivery aimed at refining combinatorial immunotherapy, offering insights into leveraging natural proteins for cancer treatment.